{
    "2018-03-01": [
        [
            {
                "time": "2018-03-01",
                "original_text": "医药与健康护理行业月报：重点关注快报表、一季报超预期个股",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "快报表",
                        "一季报",
                        "超预期"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "中航证券 沈文文：药品零售终端增速回暖，期待处方药外流带来增量",
                "features": {
                    "keywords": [
                        "药品零售",
                        "终端增速",
                        "回暖",
                        "处方药外流",
                        "增量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "[增持评级] 益丰药房(603939)深度报告：精益管理 规模渐丰的零售药店龙头",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "增持评级",
                        "精益管理",
                        "规模渐丰",
                        "零售药店",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "【医药】江琦：医药生物行业2018年3月月报：以业绩为导向，以创新为方向 - 20180301",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩导向",
                        "创新方向"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}